background
dwbc
ratio
diff
baso
count
sysmex
hereaft
defin
dtnc
total
nucleat
cell
high
effus
due
felin
infecti
periton
fip
cell
entrap
fibrin
clot
form
baso
reagent
similar
clot
form
rivalta
test
method
high
diagnost
accuraci
fip
object
object
studi
determin
diagnost
accuraci
fip
optim
cutoff
dtnc
method
retrospect
search
databas
diff
baso
count
dtnc
cat
without
fip
compar
sensit
specif
posit
neg
likelihood
ratio
lr
calcul
roc
curv
design
determin
cutoff
best
sensit
specif
result
effus
fip
nonfip
cat
analyz
dtnc
higher
p
baso
diff
count
lower
p
p
fip
nonfip
cat
fip
cat
atyp
effus
dtnc
cutoff
identifi
roc
curv
area
curv
p
sensit
specif
lr
dtnc
specif
conclus
dtnc
high
diagnost
accuraci
fiprel
effus
provid
estim
precipit
protein
rivalta
test
addit
cell
count
fibrin
clot
result
fals
lower
baso
count
dtnc
prefer
wbc
count
gener
baso
channel
alon
suspect
fip
effus
vet
clin
pathol
felin
infecti
periton
fip
ubiquit
lethal
diseas
caus
felin
coronaviru
fcov
trigger
excess
immun
respons
cat
infect
mutat
fcov
variant
antemortem
diagnosi
fip
alway
challeng
especi
noneffus
dri
form
due
variabl
clinic
sign
poor
specif
mani
laboratori
assay
among
serum
protein
electrophoresi
glycoprotein
agp
measur
may
support
clinic
suspicion
fip
howev
neither
test
provid
definit
diagnosi
fip
hand
effus
wet
form
easier
diagnos
base
signal
histori
result
biochem
test
mention
especi
analysi
effus
macroscop
typic
fip
effus
yellow
turbid
viscou
often
contain
fibrin
strand
protein
content
usual
high
decreas
albumin
globulin
ratio
cell
count
rang
l
sometim
l
cytolog
pattern
highli
suggest
definit
diagnost
fip
consist
mostli
nondegener
neutrophil
macrophag
lymphocyt
rare
plasma
cell
proteinac
background
convers
rivalta
test
recent
propos
test
high
accuraci
diagnosi
fip
rivalta
test
inexpens
easi
perform
assay
use
differenti
transud
exud
posit
reaction
acet
acid
due
presenc
high
concentr
protein
includ
fibrinogen
acut
phase
protein
visibl
clot
upon
contact
acid
compon
particularli
abund
effus
cat
fip
also
increas
effus
due
bacteri
periton
pleuriti
lymphoma
therefor
felin
medicin
rivalta
test
coupl
cytolog
effus
may
quick
way
distinguish
fip
effus
type
effus
sever
studi
demonstr
diagnost
util
rivalta
test
fip
base
high
sensit
accuraci
recent
studi
canin
felin
effus
shown
delta
tnc
ratio
total
nucleat
cell
count
tncc
diff
baso
channel
laser
counter
sysmex
report
instrument
dwbc
higher
effus
cat
affect
fip
effus
baso
channel
use
acid
reagent
induc
collaps
cell
except
basophil
fip
effus
reagent
induc
also
format
clot
entrap
cell
result
fals
low
baso
count
therefor
mechan
respons
increas
dtnc
similar
analyt
principl
rivalta
test
aim
studi
determin
diagnost
accuraci
dtnc
fip
effus
accord
standard
report
diagnost
accuraci
stard
approach
larger
number
case
assess
whether
may
diagnost
util
report
rivalta
test
defin
cutoff
valu
dtnc
minim
falseposit
neg
result
diagnosi
fip
retrospect
studi
perform
data
effus
specimen
submit
depart
veterinari
scienc
public
health
univers
milan
divet
within
routin
diagnost
activ
collect
inform
consent
owner
databas
divet
search
select
felin
intracavitari
effus
analyz
sysmex
laser
counter
period
june
june
case
includ
data
analysi
select
follow
inclus
exclus
criteria
inclus
criteria
avail
complet
document
physicochem
analysi
effus
includ
specif
graviti
protein
content
estim
refractometr
analysi
avail
extens
inform
final
diagnosi
accord
criteria
describ
avail
cytocentrifug
slide
archiv
divet
reassess
cytolog
pattern
effus
case
cytolog
report
avail
databas
exclus
criteria
absenc
followup
inform
absenc
cytolog
inform
absenc
slide
verifi
cytolog
pattern
case
without
cytolog
report
databas
unclear
nonconclus
cytolog
find
case
archiv
slide
without
inform
databas
base
criteria
cat
consid
affect
fip
result
serum
andor
effus
protein
electrophoresi
agp
serum
concentr
cytolog
pattern
effus
consist
fip
diseas
confirm
postmortem
necropsi
histopatholog
includ
posit
immunohistochemistri
fcov
describ
previou
studi
convers
cat
consid
affect
fip
cytolog
bacteriolog
effus
diagnost
diseas
fip
eventu
confirm
necropsi
histolog
followup
reveal
rapid
improv
clinic
condit
treatment
specimen
submit
laboratori
routin
diagnost
purpos
subject
cell
count
sysmex
measur
specif
graviti
protein
concentr
refractometri
clinic
refractomet
mod
sper
scientif
scottsdal
az
usa
cytolog
analysi
necropsi
addit
postmortem
test
perform
routin
necropsi
servic
divet
data
evalu
ecvcpcertifi
clinic
pathologist
unawar
dtnc
result
accord
standard
oper
procedur
laboratori
effus
collect
edta
tube
submit
later
hour
sampl
analyz
sysmex
sysmex
europ
gmbh
norderstedt
germani
analyz
determin
tncc
provid
diff
tnccdiff
baso
tnccbaso
channel
well
dtnc
specif
diff
channel
classifi
nucleat
cell
base
complex
nucleic
acid
content
baso
channel
classifi
nucleat
cell
base
volum
complex
cellular
residu
produc
contact
acid
reagent
human
blood
condens
nucleat
cell
except
basophil
effus
includ
cell
wbc
total
wbc
count
dwbc
gener
instrument
defin
tncc
dtnc
respect
purpos
studi
statist
analysi
perform
excel
microsoft
corp
redmond
wa
usa
spreadsheet
use
analyseit
softwar
analyseit
softwar
ltd
leed
uk
result
tnccdiff
tnccbaso
dtnc
record
cat
without
fip
compar
nonparametr
ttest
mannwhitney
utest
use
confid
interv
ci
measur
uncertainti
assess
diagnost
accuraci
dtnc
number
trueposit
tp
falseposit
fp
trueneg
tn
falseneg
fn
result
calcul
follow
tp
specimen
cat
fip
dtnc
higher
oper
point
tn
specimen
cat
without
fip
dtnc
lower
oper
point
fp
specimen
cat
without
fip
dtnc
higher
oper
point
fn
specimen
cat
fip
dtnc
lower
oper
point
use
number
sensit
specif
calcul
use
standard
formula
use
ci
measur
uncertainti
addit
posit
neg
likelihood
ratio
lr
respect
calcul
use
formula
lr
sensit
specif
respect
final
receiv
oper
characterist
roc
curv
design
plot
sensit
vs
determin
discrimin
power
dtnc
identifi
cat
fip
addit
optim
cutoff
valu
correspond
oper
point
closer
upper
left
corner
graph
identifi
analyt
precis
accuraci
sysmex
count
felin
effus
associ
fip
alreadi
evalu
previou
studi
specif
intraassay
coeffici
variat
cv
tnccdiff
tnccbaso
regress
coeffici
specimen
read
serial
dilut
tnccdiff
tnccbaso
studi
poor
repeat
linear
dilut
specimen
cat
fip
report
inform
actual
repeat
linear
dilut
sysmex
read
tnccdiff
tnccbaso
effus
cat
fip
inform
precis
accuraci
dtnc
report
therefor
current
studi
repeat
assess
fip
sampl
high
dtnc
specimen
normal
dtnc
consecut
measur
one
day
calcul
cv
formula
cv
meansd
assess
linear
dilut
one
specimen
high
one
normal
dtnc
serial
dilut
volvol
isoton
salin
result
dilut
correspond
origin
effus
respect
specimen
analyz
sysmex
describ
linear
determin
compar
expect
valu
dilut
valu
releas
instrument
linear
regress
analysi
retrospect
search
databas
identifi
felin
effus
origin
cat
differ
age
sex
breed
process
studi
period
june
june
figur
among
exclud
due
nonconclus
cytolog
find
lack
followup
inform
postmortem
result
remain
effus
group
follow
group
fip
n
case
except
physicochem
featur
cytolog
effus
consist
fip
show
usual
nondegener
neutrophil
macrophag
lymphocyt
rare
plasma
cell
mesotheli
cell
granular
proteinac
background
case
fip
atyp
find
effus
includ
cat
polyclon
gammopathi
high
serum
agp
concentr
effus
low
protein
concentr
gl
low
specif
graviti
low
cellular
l
rare
neutrophil
mesotheli
cell
absenc
proteinac
background
pericardi
effus
cat
reveal
high
number
reactiv
mesotheli
cell
sometim
evid
cytophagia
weakli
proteinac
background
howev
case
necropsi
reveal
typic
subseros
fibrin
lesion
associ
multipl
hemorrhag
cat
diagnosi
fip
confirm
histolog
immunohistochem
detect
intralesion
fcov
necropsi
histolog
immunohistochemistri
confirm
fip
cat
group
b
nonfip
cat
group
includ
neoplast
effus
n
due
lymphoma
n
epitheli
tumor
n
diagnos
cytolog
effus
one
thymoma
hemangiosarcoma
diagnos
detect
unclassifi
atyp
cell
effus
diagnost
imag
follow
case
hemangiosarcoma
postmortem
histolog
examin
furthermor
exud
associ
inflammatori
condit
n
diagnos
cytolog
effus
reveal
preval
popul
neutrophil
case
associ
posit
bacteriolog
effus
case
associ
clinic
laboratori
find
consist
felin
cholangiohepat
cat
recov
appropri
treatment
addit
chylou
effus
n
typic
macroscop
cytolog
appear
associ
cardiolog
abnorm
modifi
transud
n
case
associ
intraabdomin
tumor
confirm
necropsi
one
case
diagnos
cardiopath
cat
treatment
led
remiss
clinic
sign
includ
effus
shown
tabl
repeat
specimen
normal
dtnc
better
diff
baso
count
well
dtnc
cv
convers
cv
higher
extrem
variabl
specimen
high
dtnc
due
high
variabl
baso
diff
count
turn
induc
high
variabl
dtnc
linear
dilut
provid
excel
result
tnccdiff
tnccbaso
specimen
normal
dtnc
correl
coeffici
respect
p
consequ
dtnc
remain
constant
differ
dilut
correl
valu
expect
dilut
r
p
figur
convers
linear
dilut
specimen
high
dtnc
satisfactori
difftncc
r
p
diffbaso
show
expect
decreas
count
basic
provid
similar
result
independ
dilut
r
p
consequ
dtnc
decreas
linear
manner
r
p
increas
dilut
figur
figur
result
latter
cat
character
high
interindividu
variabl
like
due
heterogen
diseas
respons
effus
cat
fip
dtnc
except
cat
atyp
fip
cat
dtnc
cat
dtnc
nonfip
cat
dtnc
specif
specimen
cat
without
fip
dtnc
latter
case
cat
lymphoma
highli
cellular
effus
tnccdiff
cell
l
specimen
modifi
transud
cardiopath
cat
almost
acellular
tnccdiff
cell
l
tnccbaso
cell
l
area
roc
curv
dtnc
figur
ci
p
compar
line
discrimin
best
cutoff
dtnc
determin
roc
curv
analysi
valu
sensit
ci
specif
ci
lr
ci
ci
use
cutoff
dtnc
specif
increas
diagnosi
fip
base
combin
clinic
laboratori
find
analysi
effus
use
support
clinic
diagnosi
fip
convers
differ
diseas
rule
fip
list
differenti
diagnos
fip
contrast
diseas
character
proteinrich
effus
contain
larg
amount
globulin
particularli
cglobulin
fibrinogen
latter
react
acid
solut
rivalta
test
visibl
clot
tube
recent
rivalta
test
found
highli
diagnost
fip
although
test
specif
sensit
present
studi
investig
whether
cell
count
perform
laserbas
sysmex
socal
baso
channel
cell
count
precipit
acid
reagent
provid
diagnost
inform
similar
rivalta
test
suggest
previou
studi
howev
includ
specimen
effus
cat
fip
studi
opportun
investig
larger
number
cat
without
fip
stringent
inclus
criteria
fip
group
grant
welldefin
posit
studi
popul
unfortun
nonfip
group
compos
larg
neoplast
effus
challeng
differenti
diagnosi
fip
condit
may
easili
differenti
cytolog
therefor
possibl
limit
studi
low
number
nonneoplast
effus
routin
practic
may
benefit
addit
test
distinguish
fip
type
inflammatori
reactiv
effus
howev
also
previou
felin
effus
studi
specimen
cat
inflammatori
effus
fip
dtnc
confirm
dtnc
high
diagnost
accuraci
fip
result
current
studi
confirm
instrument
analysi
sysmex
may
repres
addit
reliabl
method
confirm
fip
analysi
effus
specif
cell
entrap
clot
form
fibrinogen
precipit
baso
channel
cell
count
baso
channel
basotncc
usual
lower
diff
channel
mechan
explain
dtnc
sysmex
refer
dwbc
increas
specimen
base
result
dtnc
high
diagnost
accuraci
fip
support
sensit
specif
roc
curv
specif
posit
likelihood
ratio
close
dtnc
make
time
like
effus
origin
cat
fip
rather
differ
diseas
convers
neg
likelihood
ratio
suggest
dtnc
probabl
effus
come
cat
fip
onetenth
probabl
effus
come
cat
differ
diseas
specif
dtnc
valu
ultim
found
fip
effus
except
atyp
case
specif
effus
one
cat
hypoalbuminemia
hemorrhag
syndrom
classifi
transud
chang
consist
liver
failur
may
induc
also
hypofibrinogenemia
like
prevent
clot
baso
reagent
case
cytolog
pattern
effus
complic
presenc
atyp
mesotheli
cell
usual
less
abund
fip
effus
neutrophil
lymphocyt
howev
may
repres
featur
typic
pericardi
effus
often
lead
misdiagnosi
neoplasia
therefor
case
falseneg
result
dtnc
may
relat
atyp
featur
effus
rather
low
analyt
sensit
regard
specif
falseposit
result
found
one
lymphoma
case
peopl
sometim
provid
posit
rivalta
test
result
possibl
due
presenc
fibrinogen
associ
inflammatori
reaction
tumor
one
case
poorli
cellular
fluid
high
dtnc
clearli
mathemat
artifact
due
analyt
sensit
instrument
howev
case
repres
diagnost
challeng
routin
practic
fip
may
easili
exclud
addit
investig
cytolog
effus
ad
diagnost
workup
independ
case
analysi
effus
counter
evidenc
sensit
specif
compar
even
higher
previous
report
rivalta
test
like
mechan
similar
rivalta
test
rapid
cheap
accur
may
limit
due
preanalyt
analyt
factor
exampl
test
may
inaccur
due
inappropri
techniqu
intrins
factor
reagent
concentr
acet
acid
differ
temperatur
effus
acet
acid
solut
moreov
reaction
may
neg
ph
increas
higher
addit
rivalta
test
provid
semiquantit
result
neg
weakli
strongli
posit
allow
grade
sever
chang
final
evalu
test
subject
inform
interobserv
variabl
current
avail
convers
analysi
counter
standard
term
reagent
although
repeat
studi
demonstr
limit
fip
effus
may
suffer
poor
precis
howev
affect
interpret
result
dtnc
alway
moreov
test
rapid
one
singl
measur
provid
inform
presenc
precipit
protein
provision
inform
cell
type
base
scattergram
addit
cell
count
howev
must
stress
linear
dilut
test
perform
studi
demonstr
accur
cell
count
provid
instrument
difftncc
affect
entrap
cell
clot
form
contact
baso
reagent
therefor
routin
practic
recommend
use
default
wbc
count
gener
baso
channel
convers
fip
clinic
suspect
may
recommend
directli
check
result
difftncc
dtnc
report
servic
screenshot
softwar
moreov
futur
studi
may
interest
assess
whether
laserbas
instrument
advia
seri
use
similar
analyt
principl
count
basophil
peripher
blood
provid
interest
result
fip
effus
conclus
studi
evidenc
high
diagnost
accuraci
sysmexgener
dtnc
diagnosi
fip
depend
format
clot
baso
reagent
entrap
cell
similarli
occur
rivalta
test
also
report
high
diagnost
accuraci
fip
reaction
lead
low
basotncc
even
difftncc
count
high
therefor
routin
practic
recommend
use
default
tncc
count
gener
baso
channel
directli
use
difftncc
especi
dtnc
particularli
fip
suspect
case
dtnc
highli
suggest
fip
dtnc
may
consid
diagnost
fip
addit
support
inform
may
found
onlin
version
articl
figur
linear
dilut
lud
record
serial
dilut
effus
specimen
cat
lymphoma
b
c
cat
fip
e
f
tabl
result
regard
repeat
record
cat
high
dtnc
associ
fip
cat
normal
dtnc
